Mathew Blackman
Stock Analyst at Stifel
(4.68)
# 193
Out of 4,736 analysts
53
Total ratings
65.79%
Success rate
23.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $18.38 | +30.58% | 5 | Nov 8, 2024 | |
| GMED Globus Medical | Maintains: Buy | $80 → $92 | $93.32 | -1.41% | 4 | Nov 6, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.81 | +65.75% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $275.84 | -13.72% | 1 | Sep 17, 2024 | |
| NARI Inari Medical | Initiates: Hold | $50 | $79.42 | -37.04% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $87.09 | +14.82% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $11.38 | +40.60% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $35.00 | +71.43% | 5 | May 29, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $10.83 | -35.36% | 12 | May 8, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $17.92 | -49.78% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $163 → $208 | $278.89 | -25.42% | 2 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $10.17 | +8.16% | 4 | May 10, 2023 |
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $18.38
Upside: +30.58%
Globus Medical
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $92
Current: $93.32
Upside: -1.41%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.81
Upside: +65.75%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $275.84
Upside: -13.72%
Inari Medical
Sep 17, 2024
Initiates: Hold
Price Target: $50
Current: $79.42
Upside: -37.04%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $87.09
Upside: +14.82%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $11.38
Upside: +40.60%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $35.00
Upside: +71.43%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $10.83
Upside: -35.36%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $17.92
Upside: -49.78%
Feb 5, 2024
Maintains: Hold
Price Target: $163 → $208
Current: $278.89
Upside: -25.42%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $10.17
Upside: +8.16%